People

TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, today announced that it has appointed Gail O’Brien Turner as Vice President, Sales.

Integra LifeSciences Holdings Corporation (NasdaqGS:IART ) announced today the appointment of Christopher A. Thatcher as President of Integra NeuroSciences, effective immediately.

Boston Scientific Corporation today announced that the Company’s Board of Directors has elected John E. Sununu as a Director.

Texcel Medical, LLC, a full service medical device process development and contract manufacturing company, has announced the appointment of Barry Smith as President and CEO.

Kinetic Concepts, Inc. today announced that in accordance with its By-Laws, the Board of Directors has increased the size of the Board from ten directors to eleven, and has appointed Mr. Craig R. Callen and Dr. Carl F. Kohrt to serve as directors.

Flamel Technologies today announced that Jeffery Vick has joined its senior management team as Flamel’s Chief Business Officer.

BioSyntech, Inc., a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that it has appointed Mr. Louis Lemire, CA, to the to the position of Chief Financial Officer.

Michael Baker, the president and CEO of ArthroCare Corp., is departing his post immediately amid revelations that the company engaged in improper behavior in its insurance billing and health care compliance practices associated with its spine business unit.

Promotes CFO Richard E. Davis to Chief Operating Officer;
Announces Retirement of President & CEO John E. Ahern;
Landmark CLOSURE I Clinical Trial Remains on Schedule

Corin Group PLC, a leading manufacturer and supplier of orthopaedic devices, has appointed Michael Roller Finance Director with effect from 2 March 2009, following the resignation of Simon Hartley on 12 February 2009.

Cytomedix, Inc. announced today that it has appointed C. Eric Winzer to its Board of Directors; Mr. Winzer will also serve as Audit Committee Chairman and the Audit Committee financial expert.

Aegis Can Now Be Marketed for Use in European Union.
Neovasc Also Announces Senior Management Changes and Issues Options.

Kensey Nash Corporation, a leading medical technology company, today announced the resignation of Mr. Jeffrey C. Smith, Partner and Portfolio Manager of Ramius LLC, from its Board of Directors.

Life sciences company Entegrion continues to strengthen its leadership team with the addition of Peter C. Johnson, MD, who will serve as Executive Vice President and Chief Business Officer, effective
immediately.

CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, announced the addition of Brent D. Mittelstadt to its senior management team as President and Chief Executive Officer.

Two important additions to Cardiac Dimension®’s senior management team. Mr. Paul Cornelison recently joined the company as Vice President of Regulatory Affairs and Quality Assurance. In addition, Mr. Nawzer Mehta, Ph.D., has joined the company as Vice President of Clinical Affairs.